3-MA treatment further reduced LC3B activation in high-CST1 cell lines under DMSO and AF treatments, indicative of autophagic activity, while CQ treatment further elevated the activation of LC3B-II form (Figure 3c). This evidence concerns the gene CST1 and atrial fibrillation.